Life Sciences Tools & Services (149) | Stock Agreements (149)
Browse by Company
-
10x Genomics, Inc. (6)
-
AbCellera Biologics Inc. (1)
-
AbSci Corp (3)
-
Adaptive Biotechnologies Corp (3)
-
Agilent Technologies Inc (1)
-
Akoya Biosciences, Inc. (1)
-
Alpha Teknova, Inc. (5)
-
ARYA Sciences Acquisition Corp III (4)
-
Avantor, Inc. (6)
-
Berkeley Lights, Inc. (2)
-
Bio-Matrix Scientific Group, Inc. (4)
-
Bio-Rad Laboratories (1)
-
Bio-Techne (12)
-
BIOANALYTICAL SYSTEMS INC (1)
-
BioNano Genomics, Inc (4)
-
Charles River Laboratories (1)
-
ChromaDex Corp. (2)
-
CM Life Sciences II Inc. (4)
-
Codex DNA, Inc. (3)
-
CODEXIS INC (1)
-
Cytek BioSciences, Inc. (2)
-
FLUIDIGM CORP (3)
-
HARVARD BIOSCIENCE INC (3)
-
HighCape Capital Acquisition Corp. (5)
-
Illumina Inc (1)
-
INTERNATIONAL ISOTOPES INC (1)
-
IsoPlexis Corp (5)
-
Lifesci Acquisition II Corp. (6)
-
MARAVAI LIFESCIENCES HOLDINGS, INC. (3)
-
Mettler Toledo (2)
-
Miromatrix Medical Inc. (11)
-
NanoString Technologies Inc (1)
-
NEOGENOMICS INC (1)
-
Personalis, Inc. (2)
-
PPD, Inc. (1)
-
PRA Health Sciences (1)
-
RAPID MICRO BIOSYSTEMS, INC. (4)
-
Repligen Corporation (1)
-
Seer, Inc. (7)
-
SeqLL, Inc. (6)
-
Singular Genomics Systems, Inc. (2)
-
Sotera Health Co (2)
-
Syneos Health (2)
-
Thermo Fisher Scientific (5)
-
VG Acquisition Corp. (7)
Recent Contracts
-
Harvard Bioscience, Inc. Employee Stock Purchase Plan, as amended
(HARVARD BIOSCIENCE INC, Filed With SEC on May 17, 2022)
-
Description of Capital Stock
(IsoPlexis Corp, Filed With SEC on March 30, 2022)
-
Description of Capital Stock
(RAPID MICRO BIOSYSTEMS, INC., Filed With SEC on March 24, 2022)
-
Description of the Registrants capital stock
(Alpha Teknova, Inc., Filed With SEC on March 18, 2022)
-
Stock Restriction Agreement
(BioNano Genomics, Inc, Filed With SEC on March 1, 2022)
-
Stock Purchase Agreement, dated January 27, 2022, by and among Envigo Global Services Inc., Inotiv, Inc., and Orient Bio, Inc
(BIOANALYTICAL SYSTEMS INC, Filed With SEC on January 31, 2022)
-
Series B-1 Convertible Preferred Stock Purchase Agreement, dated as of January 23, 2022, by and among Fluidigm Corporation, Casdin Private Growth Equity Fund II, L.P., and Casdin...
(FLUIDIGM CORP, Filed With SEC on January 24, 2022)
-
Series B-2 Convertible Preferred Stock Purchase Agreement, dated as of January 23, 2022, by and among Fluidigm Corporation, Viking Global Opportunities Illiquid Investments...
(FLUIDIGM CORP, Filed With SEC on January 24, 2022)
-
Charles River Laboratories International, Inc. Restricted Stock Unit Award dated December 25, 2021 granted to Joseph W. LaPlume
(Charles River Laboratories, Filed With SEC on December 27, 2021)
-
Stock Sale Agreement between the Company and Mr. Witherill dated September 27, 2021
(Bio-Matrix Scientific Group, Inc., Filed With SEC on November 29, 2021)
